WELLS FARGO & COMPANY/MN - TEKMIRA PHARMACEUTICALS CORP ownership

TEKMIRA PHARMACEUTICALS CORP's ticker is TKMR and the CUSIP is 87911B209. A total of 79 filers reported holding TEKMIRA PHARMACEUTICALS CORP in Q1 2015. The put-call ratio across all filers is 1.09 and the average weighting 0.3%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of TEKMIRA PHARMACEUTICALS CORP
ValueSharesWeighting
Q2 2015$36,000
-62.5%
3,060
-44.6%
0.00%
Q1 2015$96,000
+1271.4%
5,520
+1100.0%
0.00%
Q4 2014$7,000
-12.5%
460
+15.0%
0.00%
Q3 2014$8,000
-99.9%
400
-99.9%
0.00%
-100.0%
Q2 2014$10,254,000
-39.6%
785,138
-0.6%
0.00%
-42.9%
Q1 2014$16,971,000
+1697000.0%
789,683
+394741.5%
0.01%
Q3 2013$1,0000.0%2000.0%0.00%
Q2 2013$1,0002000.00%
Other shareholders
TEKMIRA PHARMACEUTICALS CORP shareholders Q1 2015
NameSharesValueWeighting ↓
QVT Financial LP 16,013,540$279,596,00015.57%
RA Capital Management 2,714,800$47,400,0004.71%
Alpha Wave Global, LP 2,221,000$38,779,0001.90%
Redmile Group, LLC 700,000$12,222,0001.10%
HealthCor Management, L.P. 718,800$12,550,0000.60%
Monashee Investment Management LLC 55,000$960,0000.60%
SPHERA FUNDS MANAGEMENT LTD. 298,486$5,212,0000.54%
Telemetry Investments, L.L.C. 48,000$838,0000.46%
Anson Funds Management LP 25,000$437,0000.39%
Blue Ridge Capital, L.L.C. 1,700,000$29,682,0000.34%
View complete list of TEKMIRA PHARMACEUTICALS CORP shareholders